Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
490.6 INR | -0.35% | -2.82% | +0.16% |
Mar. 29 | Aarti Drugs Limited Announces Executive Cessation | CI |
Jan. 31 | Aarti Drugs Begins Manufacturing Dermatology Products in Tarapur, India Facility | MT |
Sales 2024 * | 26.12B 313M | Sales 2025 * | 29.48B 353M | Capitalization | 45.35B 543M |
---|---|---|---|---|---|
Net income 2024 * | 1.73B 20.73M | Net income 2025 * | 2.52B 30.13M | EV / Sales 2024 * | 1.74 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.54 x |
P/E ratio 2024 * |
26.4
x | P/E ratio 2025 * |
18.1
x | Employees | 1,003 |
Yield 2024 * |
0.95% | Yield 2025 * |
1.38% | Free-Float | 36.93% |
Latest transcript on Aarti Drugs Limited
1 day | -0.48% | ||
1 week | -2.82% | ||
Current month | +12.83% | ||
1 month | +9.89% | ||
3 months | -7.96% | ||
6 months | -10.09% | ||
Current year | +0.16% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 76 | 85-01-04 | |
Adhish P. Patil
DFI | Director of Finance/CFO | 41 | 12-07-05 |
Rushikesh Deole
CMP | Compliance Officer | - | 19-04-22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 76 | 85-01-04 | |
Director/Board Member | 61 | 87-01-01 | |
Director/Board Member | 60 | 95-09-14 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 490.6 | -0.35% | 31 506 |
24-04-18 | 492.4 | -0.49% | 110,702 |
24-04-16 | 494.8 | +0.85% | 81,950 |
24-04-15 | 490.6 | -2.70% | 146,188 |
24-04-12 | 504.2 | -0.74% | 124,404 |
Delayed Quote NSE India S.E., April 19, 2024 at 01:27 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+27.97% | 672B | |
+23.58% | 550B | |
-7.02% | 351B | |
+14.85% | 317B | |
+6.25% | 292B | |
+2.96% | 211B | |
-0.41% | 203B | |
-10.02% | 194B | |
-11.81% | 144B |
- Stock Market
- Equities
- AARTIDRUGS Stock
- AARTIDRUGS Stock